BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 1501299)

  • 1. The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle.
    Yu X; Yu QC; Lee TH; Essex M
    J Virol; 1992 Sep; 66(9):5667-70. PubMed ID: 1501299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.
    Yu X; Yuan X; Matsuda Z; Lee TH; Essex M
    J Virol; 1992 Aug; 66(8):4966-71. PubMed ID: 1629961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.
    Kiernan RE; Ono A; Englund G; Freed EO
    J Virol; 1998 May; 72(5):4116-26. PubMed ID: 9557701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes.
    Lee YM; Tang XB; Cimakasky LM; Hildreth JE; Yu XF
    J Virol; 1997 Feb; 71(2):1443-52. PubMed ID: 8995670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.
    Poon DT; Li G; Aldovini A
    J Virol; 1998 Mar; 72(3):1983-93. PubMed ID: 9499052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversion of a human immunodeficiency virus type 1 matrix mutation affecting Gag membrane binding, endogenous reverse transcriptase activity, and virus infectivity.
    Kiernan RE; Ono A; Freed EO
    J Virol; 1999 Jun; 73(6):4728-37. PubMed ID: 10233933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
    Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the conserved cysteine residues in the simian immunodeficiency virus matrix protein.
    González SA; Affranchino JL
    Virology; 1995 Jul; 210(2):501-7. PubMed ID: 7618287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insertion of a classical nuclear import signal into the matrix domain of the Rous sarcoma virus Gag protein interferes with virus replication.
    Garbitt RA; Bone KR; Parent LJ
    J Virol; 2004 Dec; 78(24):13534-42. PubMed ID: 15564464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein.
    Ott DE; Chertova EN; Busch LK; Coren LV; Gagliardi TD; Johnson DG
    J Virol; 1999 Jan; 73(1):19-28. PubMed ID: 9847302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant.
    Wang CT; Zhang Y; McDermott J; Barklis E
    J Virol; 1993 Dec; 67(12):7067-76. PubMed ID: 7693966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.
    Chazal N; Gay B; Carrière C; Tournier J; Boulanger P
    J Virol; 1995 Jan; 69(1):365-75. PubMed ID: 7983731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 matrix mutations that alter gag membrane binding modulate mature core formation and post-entry events.
    Hikichi Y; Takeda E; Fujino M; Nakayama E; Matano T; Murakami T
    Virology; 2019 Jun; 532():97-107. PubMed ID: 31055063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of human immunodeficiency virus type 1 matrix phosphorylation in an early postentry step of virus replication.
    Kaushik R; Ratner L
    J Virol; 2004 Mar; 78(5):2319-26. PubMed ID: 14963128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions.
    Ono A; Huang M; Freed EO
    J Virol; 1997 Jun; 71(6):4409-18. PubMed ID: 9151831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compensatory point mutations in the human immunodeficiency virus type 1 Gag region that are distal from deletion mutations in the dimerization initiation site can restore viral replication.
    Liang C; Rong L; Laughrea M; Kleiman L; Wainberg MA
    J Virol; 1998 Aug; 72(8):6629-36. PubMed ID: 9658109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitution of leucine 8 in the simian immunodeficiency virus matrix protein impairs particle formation without affecting N-myristylation of the Gag precursor.
    González SA; Affranchino JL
    Virology; 1998 Jan; 240(1):27-35. PubMed ID: 9448686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions.
    Yu X; Yuan X; McLane MF; Lee TH; Essex M
    J Virol; 1993 Jan; 67(1):213-21. PubMed ID: 8416370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes.
    Anderson-Daniels J; Singh PK; Sowd GA; Li W; Engelman AN; Aiken C
    J Virol; 2019 Nov; 93(21):. PubMed ID: 31413124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of domains in the simian immunodeficiency virus matrix protein essential for assembly and envelope glycoprotein incorporation.
    González SA; Burny A; Affranchino JL
    J Virol; 1996 Sep; 70(9):6384-9. PubMed ID: 8709267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.